| Dr Michael Kwame Turner, MD | |
|
1350 N Grant St, Kennewick, WA 99336-1355 | |
| (509) 349-3010 | |
| (509) 769-0944 |
| Full Name | Dr Michael Kwame Turner |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 1350 N Grant St, Kennewick, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356454003 | NPI | - | NPPES |
| MD60072206 | Other | WA | STATE LICENSE |
| 0255541 | Other | WA | DEPT LABOR & INDUSTRIES |
| 8544710 | Medicaid | WA |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Kwame Turner, MD 3321 Mt Adams View Dr, West Richland, WA 99353 Ph: (509) 438-9561 | Dr Michael Kwame Turner, MD 1350 N Grant St, Kennewick, WA 99336-1355 Ph: (509) 349-3010 |
News Archive
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
Scientific advances in understanding the "addiction circuitry" of the brain may lead to effective treatment for obesity using deep brain stimulation (DBS), according to a review article in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that the ANSM, French healthcare agency, has granted the authorization to start a Phase II study in second line treatment of patients affected by pancreatic cancer.
The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis (TB). The TB Alliance is a not-for-profit, product development partnership, whose goal is the development of new TB drugs.
Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.
› Verified 3 days ago
Dr. Jean You, M.D Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8904 W Tucannon Ave, Kennewick, WA 99336 Phone: 509-627-2848 Fax: 509-627-2849 | |
Dr. John B Groner, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4309 W 27th Pl Ste 202, Kennewick, WA 99338 Phone: 509-591-4966 Fax: 509-396-5033 | |
Linda Lee Walby, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4309 W 27th Pl Ste B302, Kennewick, WA 99338 Phone: 509-591-4427 Fax: 509-820-3160 | |
Katherine Sanderson, DPT, CIMI, NTMTC, DC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 507 S Hawaii St, Kennewick, WA 99336 Phone: 509-627-8161 | |
Dr. John A Cadwell, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 909 N Kellogg St, Kennewick, WA 99336 Phone: 509-735-6481 Fax: 509-783-6502 |